Sanjay Rajagopalan MD
Cardiothoracic Imaging, Preventive Cardiology
Chief Cardiovascular Medicine, Chief Academic and Scientific Officer. Harrington Heart and Vascular Institute. University Hospitals Health System. Herman Hellerstein Professor of Cardiovascular Research. Director, Case Cardiovascular Research Institute. Professor of Medicine, Radiology and Biomedical Engineering. Case Western Reserve School of Medicine, Cleveland, OH.
Join to View Full Profile
11100 Euclid AveCleveland, OH 44106
Phone+1 216-844-1000
Dr. Rajagopalan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sanjay Rajagopalan is a distinguished leader and innovator in cardiovascular medicine, with over 20 years of experience in clinical, academic, and scientific roles. He is currently the Chief of Cardiovascular Medicine, Herman Hellerstein, MD Professor of Cardiovascular Research, Chief Academic and Scientific Officer at University Hospitals (UH) Harrington Heart and Vascular Institute and Director of the Case Cardiovascular Research Institute at Case Western Reserve School of Medicine. With an MBA from the Sloan School at the Massachusetts Institute of Technology (MIT), he has substantial expertise in the health care transformation, innovation, team leadership and strategy. His additional areas of interest/expertise include precision medicine, sustainability, and environmental health.
Education & Training
Massachusetts Institute of TechnologyMBA, Management, 2021 - 2033
Duke University School of MedicineCardiovascular MRI, 2002 - 2003
Emory University School of MedicineFellowship, Cardiovascular Disease, 1994 - 1998
University at BuffaloResidency, Internal Medicine, 1990 - 1994
Stanley Medical College SMCClass of 1990
Certifications & Licensure
OH State Medical License 2006 - 2026
MD State Medical License 2013 - 2017
MI State Medical License 1993 - 2008
NY State Medical License 2004 - 2007
GA State Medical License 1994 - 1999
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Aliskerin Effect on Plaque Progression in Established Atherosclerosis Using High Resolution 3D MRI: A Double Blind Placebo Controlled Trial Start of enrollment: 2010 Mar 01
- Aliskiren Effect on Aortic Plaque Progression Start of enrollment: 2009 Oct 01
- Environmental Triggers Of Cardiometabolic Disease Start of enrollment: 2011 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsEnvironmental sustainability in cardiovascular practice: current challenges and future directions.Sanjay Rajagopalan, Scott McAlister, Jason Jay, Richard D Pham, Robert D Brook
Nature Reviews. Cardiology. 2025-04-01 - Environmental Hypertensionology and the Mosaic Theory of Hypertension.Sanjay Rajagopalan, Robert D Brook, Thomas Münzel
Hypertension. 2025-04-01 - The community health worker model for cardiovascular kidney metabolic syndrome: A new paradigm for high value care.Sanjay Rajagopalan, Jeshurun Adarquah-Yiadom, Fonda Mcclain, John Pastor Ansah, Heidi Osborne
American Journal of Preventive Cardiology. 2025-03-01
Journal Articles
- Air Pollution and Cardiovascular DiseaseSanjay Rajagopalan, MD, ScienceDirect
- Central IKK2 Inhibition Ameliorates Air Pollution-Mediated Hepatic Glucose and Lipid Metabolism Dysfunction in Mice with Type II DiabetesSanjay Rajagopalan, MD, Toxicological Sciences
Authored Content
- Reply Pollution and Organ TransplantationJune 2020
Press Mentions
Extreme Heat Seems to Spark More Atrial Arrhythmias in IED PatientsNovember 19th, 2024- Extreme Heat May Increase Risk of Irregular Heartbeat in People with Implanted DefibrillatorsNovember 11th, 2024
- Triple-Digit Heat Waves Could Pose Danger to Implanted DefibrillatorsNovember 11th, 2024
- Join now to see all
Grant Support
- (CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air PollutionCASE WESTERN RESERVE UNIVERSITY2021–2029
- (CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air PollutionCASE WESTERN RESERVE UNIVERSITY2021–2029
- (CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air PollutionCASE WESTERN RESERVE UNIVERSITY2021–2029
- (CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air PollutionCASE WESTERN RESERVE UNIVERSITY2021–2029
- (CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air PollutionCASE WESTERN RESERVE UNIVERSITY2021–2029
- (CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air PollutionCASE WESTERN RESERVE UNIVERSITY2021–2029
- Pericoronary fat: MACE risk from non-contrast CT and the role of iodine perfusion in contrast CTCASE WESTERN RESERVE UNIVERSITY2023–2027
- Cardiovascular risk from comprehensive evaluation of the CT calcium score examCASE WESTERN RESERVE UNIVERSITY2023–2027
- Targets and targeting of immunometabolism in chronic PM2.5 exposureCASE WESTERN RESERVE UNIVERSITY2022–2026
- Targets and targeting of immunometabolism in chronic PM2.5 exposureCASE WESTERN RESERVE UNIVERSITY2022–2026
- Targets and targeting of immunometabolism in chronic PM2.5 exposureCASE WESTERN RESERVE UNIVERSITY2022–2026
- Targets and targeting of immunometabolism in chronic PM2.5 exposureCASE WESTERN RESERVE UNIVERSITY2022–2026
- Targets and targeting of immunometabolism in chronic PM2.5 exposureCASE WESTERN RESERVE UNIVERSITY2022–2026
- Targets and targeting of immunometabolism in chronic PM2.5 exposureCASE WESTERN RESERVE UNIVERSITY2022–2026
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
